Suppr超能文献

术中应用受体特异性与被动递送荧光剂的近红外成像技术在垂体腺瘤中的应用。

Intraoperative near-infrared imaging with receptor-specific versus passive delivery of fluorescent agents in pituitary adenomas.

机构信息

Departments of1Neurosurgery.

4Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; and.

出版信息

J Neurosurg. 2018 Dec 14;131(6):1974-1984. doi: 10.3171/2018.7.JNS181642. Print 2019 Dec 1.

Abstract

OBJECTIVE

Intraoperative molecular imaging with tumor-targeted fluorescent dyes can enhance resection rates. In contrast to visible-light fluorophores (e.g., 5-aminolevulinic-acid), near-infrared (NIR) fluorophores have increased photon tissue penetration and less contamination from tissue autofluorescence. The second-window ICG (SWIG) technique relies on passive accumulation of indocyanine green (ICG) in neoplastic tissues. OTL38, conversely, targets folate receptor overexpression in nonfunctioning pituitary adenomas. In this study, we compare the properties of these 2 modalities for NIR imaging of pituitary adenomas to better understand the potential for NIR imaging in neurosurgery.

METHODS

A total of 39 patients with pituitary adenomas were enrolled between June 2015 and January 2018 in 2, sequential, IRB-approved studies. Sixteen patients received systemic ICG infusions 24 hours prior to surgery, and another 23 patients received OTL38 infusions 2-3 hours prior to surgery. NIR fluorescence signal-to-background ratio (SBR) was recorded during and after resection. Immunohistochemistry was performed on the 23 adenomas resected from patients who received OTL38 to assess expression of folate receptor-alpha (FRα).

RESULTS

All 16 adenomas operated on after ICG administration demonstrated strong NIR fluorescence (mean SBR 4.1 ± 0.69 [SD]). There was no statistically significant difference between the 9 functioning and 7 nonfunctioning adenomas (p = 0.9). After administration of OTL38, the mean SBR was 1.7 ± 0.47 for functioning adenomas, 2.6 ± 0.91 for all nonfunctioning adenomas, and 3.2 ± 0.53 for the subset of FRα-overexpressing adenomas. Tissue identification with white light alone for all adenomas demonstrated 88% sensitivity and 90% specificity. SWIG demonstrated 100% sensitivity but only 29% specificity for both functioning and nonfunctioning adenomas. OTL38 was 75% sensitive and 100% specific for all nonfunctioning adenomas, but when assessment was limited to the 9 FRα-overexpressing adenomas, the sensitivity and specificity of OTL38 were both 100%.

CONCLUSIONS

Intraoperative imaging with NIR fluorophores demonstrates highly sensitive detection of pituitary adenomas. OTL38, a folate-receptor-targeted fluorophore, is highly specific for nonfunctioning adenomas but has no utility in functioning adenomas. SWIG, which relies on passive diffusion into neoplastic tissue, is applicable to both functioning and nonfunctioning pituitary adenomas, but it is less specific than targeted fluorophores. Thus, targeted and nontargeted NIR fluorophores play important, yet distinct, roles in intraoperative imaging. Selectively and intelligently using either agent has the potential to greatly improve resection rates and outcomes for patients with intracranial tumors.

摘要

目的

术中应用肿瘤靶向荧光染料进行分子成像可以提高切除率。与可见光荧光团(如 5-氨基酮戊酸)相比,近红外(NIR)荧光团具有增加的光子组织穿透性和较少的组织自发荧光污染。第二窗口吲哚菁绿(ICG)技术依赖于吲哚菁绿(ICG)在肿瘤组织中的被动积累。相反,OTL38 靶向无功能垂体腺瘤中的叶酸受体过表达。在这项研究中,我们比较了这两种模态用于垂体腺瘤的近红外成像的特性,以更好地了解近红外成像在神经外科中的潜力。

方法

2015 年 6 月至 2018 年 1 月,共有 39 例垂体腺瘤患者连续入组了 2 项经 IRB 批准的研究。16 例患者在术前 24 小时接受全身 ICG 输注,另有 23 例患者在术前 2-3 小时接受 OTL38 输注。在切除过程中和切除后记录近红外荧光信号与背景的比值(SBR)。对接受 OTL38 治疗的 23 例腺瘤患者切除的腺瘤进行免疫组织化学染色,以评估叶酸受体-α(FRα)的表达。

结果

所有在 ICG 给药后进行手术的 16 例腺瘤均表现出强烈的近红外荧光(平均 SBR 为 4.1 ± 0.69 [SD])。功能腺瘤和无功能腺瘤之间没有统计学上的显著差异(p = 0.9)。在 OTL38 给药后,功能腺瘤的平均 SBR 为 1.7 ± 0.47,所有无功能腺瘤的平均 SBR 为 2.6 ± 0.91,FRα 过表达腺瘤的平均 SBR 为 3.2 ± 0.53。所有腺瘤仅用白光进行组织识别的敏感性为 88%,特异性为 90%。SWIG 对功能腺瘤和无功能腺瘤的敏感性均为 100%,但特异性仅为 29%。OTL38 对所有无功能腺瘤的敏感性为 75%,特异性为 100%,但当评估仅限于 9 例 FRα 过表达腺瘤时,OTL38 的敏感性和特异性均为 100%。

结论

近红外荧光团的术中成像显示出对垂体腺瘤的高度敏感检测。OTL38 是一种叶酸受体靶向荧光团,对无功能腺瘤具有高度特异性,但对功能腺瘤没有作用。SWIG 依赖于被动扩散进入肿瘤组织,适用于功能腺瘤和无功能腺瘤,但特异性低于靶向荧光团。因此,靶向和非靶向近红外荧光团在术中成像中发挥着重要而独特的作用。有选择性地和智能地使用这两种试剂有可能极大地提高颅内肿瘤患者的切除率和治疗效果。

相似文献

1
术中应用受体特异性与被动递送荧光剂的近红外成像技术在垂体腺瘤中的应用。
J Neurosurg. 2018 Dec 14;131(6):1974-1984. doi: 10.3171/2018.7.JNS181642. Print 2019 Dec 1.
2
近红外成像可实时观察到垂体腺瘤经蝶窦内镜手术中叶酸受体的过度表达。
J Neurosurg. 2018 Aug;129(2):390-403. doi: 10.3171/2017.2.JNS163191. Epub 2017 Aug 25.
3
叶酸受体近红外光学成像是一种敏感且特异的非功能性垂体腺瘤术中可视化方法。
Oper Neurosurg (Hagerstown). 2019 Jan 1;16(1):59-70. doi: 10.1093/ons/opy034.
4
术中垂体腺瘤荧光可视化。
Neurosurg Clin N Am. 2019 Oct;30(4):401-412. doi: 10.1016/j.nec.2019.05.002. Epub 2019 Jul 27.
5
内镜经鼻颅底手术中颅底肿瘤的近红外光学对比。
Oper Neurosurg (Hagerstown). 2019 Jul 1;17(1):32-42. doi: 10.1093/ons/opy213.
6
近红外荧光引导下的颅内脑膜瘤手术。
J Neurosurg. 2018 Feb;128(2):380-390. doi: 10.3171/2016.10.JNS161636. Epub 2017 Apr 7.
7
近红外荧光结合第二窗口吲哚菁绿在颅底手术中辅助定位垂体柄
World Neurosurg. 2020 Apr;136:326. doi: 10.1016/j.wneu.2020.01.135. Epub 2020 Jan 26.
8
在垂体腺瘤手术中使用光学荧光剂:该领域的现状。
J Neurooncol. 2019 Feb;141(3):585-593. doi: 10.1007/s11060-018-03062-2. Epub 2018 Dec 6.
10
荧光引导下经蝶窦内镜手术中垂体神经内分泌肿瘤(PitNET)组织的检测——现有试剂、潜在应用及技术要点。
Rev Endocr Metab Disord. 2022 Jun;23(3):647-657. doi: 10.1007/s11154-022-09718-9. Epub 2022 Mar 28.

引用本文的文献

1
吲哚菁绿荧光在内镜经蝶窦切除垂体神经内分泌肿瘤中的应用:一项系统评价
Acta Neurochir (Wien). 2025 Mar 28;167(1):92. doi: 10.1007/s00701-025-06500-z.
2
洞悉不可见之物:神经外科手术中术中荧光的应用、局限性及前景
Brain Spine. 2024 Oct 10;4:103928. doi: 10.1016/j.bas.2024.103928. eCollection 2024.
3
颅底手术中的荧光引导:应用与局限性——一项系统综述
Brain Spine. 2024 Aug 29;4:103328. doi: 10.1016/j.bas.2024.103328. eCollection 2024.
4
术中使用人工智能方法对直肠癌进行近红外功能成像——现在和不久的将来的最新技术。
Eur J Nucl Med Mol Imaging. 2024 Aug;51(10):3135-3148. doi: 10.1007/s00259-024-06731-9. Epub 2024 Jun 11.
5
迟发性吲哚菁绿荧光的机制及其在临床疾病过程中的应用。
Surgery. 2024 Aug;176(2):386-395. doi: 10.1016/j.surg.2024.03.053. Epub 2024 May 14.
6
术中分子影像学:第三届两年期临床试验更新。
J Biomed Opt. 2023 May;28(5):050901. doi: 10.1117/1.JBO.28.5.050901. Epub 2023 May 13.
7
吲哚菁绿荧光成像在外科肿瘤学中的主要应用。
Front Surg. 2023 Feb 17;10:1077492. doi: 10.3389/fsurg.2023.1077492. eCollection 2023.
8
侧入式术中超声在垂体大腺瘤和巨大腺瘤切除术中的应用:一项单中心回顾性病例对照研究
Front Oncol. 2022 Nov 30;12:1043697. doi: 10.3389/fonc.2022.1043697. eCollection 2022.
9
术中使用帕拉福酰胺检测肿瘤。
Int J Mol Sci. 2022 Oct 25;23(21):12842. doi: 10.3390/ijms232112842.
10
内镜颅底手术中可视化技术的现状
Brain Sci. 2022 Oct 3;12(10):1337. doi: 10.3390/brainsci12101337.

本文引用的文献

1
叶酸受体近红外光学成像是一种敏感且特异的非功能性垂体腺瘤术中可视化方法。
Oper Neurosurg (Hagerstown). 2019 Jan 1;16(1):59-70. doi: 10.1093/ons/opy034.
2
肿瘤切除中的荧光成像/试剂
Neurosurg Clin N Am. 2017 Oct;28(4):569-583. doi: 10.1016/j.nec.2017.05.009. Epub 2017 Aug 18.
3
近红外成像可实时观察到垂体腺瘤经蝶窦内镜手术中叶酸受体的过度表达。
J Neurosurg. 2018 Aug;129(2):390-403. doi: 10.3171/2017.2.JNS163191. Epub 2017 Aug 25.
4
用于颅内肿瘤检测的近红外成像摄像系统比较。
Mol Imaging Biol. 2018 Apr;20(2):213-220. doi: 10.1007/s11307-017-1107-5.
5
术中近红外光学造影可定位脑转移瘤。
World Neurosurg. 2017 Oct;106:120-130. doi: 10.1016/j.wneu.2017.06.128. Epub 2017 Jun 30.
6
从外视镜迈向新一代。
J Korean Neurosurg Soc. 2017 May;60(3):289-293. doi: 10.3340/jkns.2017.0202.003. Epub 2017 May 1.
7
近红外荧光引导下的颅内脑膜瘤手术。
J Neurosurg. 2018 Feb;128(2):380-390. doi: 10.3171/2016.10.JNS161636. Epub 2017 Apr 7.
8
术中近红外光学成像可在手术期间定位钆增强型胶质瘤。
Neurosurgery. 2016 Dec;79(6):856-871. doi: 10.1227/NEU.0000000000001450.
10
荧光引导手术系统的评价:超越吲哚菁绿成像的关键性能能力的识别。
J Biomed Opt. 2016 Aug 1;21(8):80901. doi: 10.1117/1.JBO.21.8.080901.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验